Nine triple-negative breast cancer (TNBC) patient tumor samples were stained with Probody constructs containing either a selective uPA substrate (Pb-S02) or an MMP-14 substrate (SLAPLGLQRR)21, termed Pb-M02 (Supplementary Table 2). Here, PLAU is linked to triple-negative breast carcinoma.